These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 347303)
61. Don't ban genetic engineering. Capron AM Washington Post; 1983 Jun; ():A29. PubMed ID: 11646283 [No Abstract] [Full Text] [Related]
62. ET recombination: DNA engineering using homologous recombination in E. coli. Muyrers JP; Zhang Y; Benes V; Testa G; Rientjes JM; Stewart AF Methods Mol Biol; 2004; 256():107-21. PubMed ID: 15024163 [No Abstract] [Full Text] [Related]
63. Biotechnology: can a new technology survive? Withers WW; Kenworthy PG St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845 [No Abstract] [Full Text] [Related]
64. Britain opens biotech regulation to greater public involvement. Masood E Nature; 1999 May; 399(6734):287-8. PubMed ID: 10360555 [No Abstract] [Full Text] [Related]
65. Genetics and the law: a scientist's view. Singer MF Yale Law Policy Rev; 1985; 3(2):315-35. PubMed ID: 11652467 [No Abstract] [Full Text] [Related]
66. Danes wary about engineered animals. Radin P New Sci; 1992 Oct; 135(1841):5. PubMed ID: 11656161 [No Abstract] [Full Text] [Related]
67. [Use of radioisotopes in recombinant DNA research]. Takagi Y Radioisotopes; 1984 Feb; 33(2):91-9. PubMed ID: 6330794 [No Abstract] [Full Text] [Related]
68. Discussions on human gene therapy. Milewski EA Recomb DNA Tech Bull; 1986 Jun; 9(2):88-130. PubMed ID: 3532218 [No Abstract] [Full Text] [Related]
69. Human gene therapy: application, ethics and regulation. Baskerville G Dickinson Law Rev; 1992; 96(4):733-63. PubMed ID: 11652212 [No Abstract] [Full Text] [Related]
70. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986. Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693 [No Abstract] [Full Text] [Related]
72. Some aspects of the preclinical safety of drugs produced by recombinant DNA technology: Japanese government regulatory position. Hayakawa T Prog Clin Biol Res; 1987; 235():15-29. PubMed ID: 3299390 [No Abstract] [Full Text] [Related]
73. Guess what's coming to dinner? Vines G New Sci; 1992 Nov; 136(1847):13-4. PubMed ID: 11656186 [No Abstract] [Full Text] [Related]
74. Recombinant DNA research; proposed actions under guidelines; notice. U.S. National Institutes of Health Fed Regist; 1988 Apr; 53(74):12752-4. PubMed ID: 11655890 [No Abstract] [Full Text] [Related]
75. The public and recombinant DNA research. Callahan D Conn Med; 1977 Sep; 41(9):569-73. PubMed ID: 902480 [No Abstract] [Full Text] [Related]
76. Philosophical and moral aspects of manipulation and of risk. Sass HM Swiss Biotech; 1987; 5(2a):50-6. PubMed ID: 11658838 [No Abstract] [Full Text] [Related]
78. Altered minds: so the Swiss don't hate genetic engineering after all. Klaffke O New Sci; 1998 Jun; 158(2138):5. PubMed ID: 11657475 [No Abstract] [Full Text] [Related]
79. Recombinant DNA research: proposed actions under guidelines. US National Institutes of Health Fed Regist; 1984 Sep; 49(184):37016-7. PubMed ID: 11645519 [No Abstract] [Full Text] [Related]
80. Recombinant DNA: science and the public. Callahan D Hastings Cent Rep; 1977 Apr; 7(2):20-3. PubMed ID: 863700 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]